BiotechTube
Home/Prevail Therapeutics/Asa Abeliovich, MD, PhD
AA

Asa Abeliovich, MD, PhD

Founder

Prevail Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesRare DiseasesLysosomal Storage Disorders

Prevail Therapeutics Pipeline

DrugIndicationPhase
PR001 (LY3884961)Parkinson's Disease with GBA1 MutationsPhase 1/2
PR006GRN-associated Frontotemporal DementiaPhase 1/2